Immediate Impact
4 from Science/Nature 62 standout
Citing Papers
Pancreatic cancer
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Works of Marc Hilmi being referenced
Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinoma
2021
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Marc Hilmi | 408 | 125 | 123 | 164 | 33 | 683 | |
| Chengzeng Yin | 331 | 161 | 127 | 177 | 28 | 621 | |
| Naoki Umezaki | 334 | 108 | 348 | 86 | 35 | 640 | |
| Yizhen Gong | 180 | 174 | 89 | 245 | 48 | 672 | |
| J. Alexandre | 363 | 60 | 145 | 167 | 44 | 738 | |
| Sophie Broutin | 299 | 120 | 107 | 208 | 47 | 757 | |
| Jialiang Gan | 299 | 153 | 112 | 121 | 42 | 625 | |
| Nivedita Arora | 284 | 101 | 102 | 228 | 38 | 633 | |
| Massimiliano Salati | 375 | 165 | 193 | 193 | 25 | 705 | |
| V. Fanotto | 476 | 188 | 108 | 163 | 32 | 837 | |
| Finn Ole Larsen | 530 | 102 | 234 | 88 | 49 | 843 |
All Works
Login with ORCID to disown or claim papers
Loading papers...